Literature DB >> 2901844

Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells.

M Russo1, N Starobinas, P Minoprio, A Coutinho, M Hontebeyrie-Joskowicz.   

Abstract

In order to characterize the role played by CD4+ T lymphocytes in the immunopathology of acute Trypanosoma cruzi infection, we compared the numbers of blood and tissue parasites and the heart inflammatory reaction in normal and anti-CD4 antibody-treated C3H mice. Treatment of mice with anti-CD4 mAb during acute infection markedly inhibited T-helper-cell-dependent activities, as measured by peritoneal macrophage activation and immunoglobulin secretion by splenic B lymphocytes. After in vivo inactivation of helper T cells, the number of blood and tissue parasites significantly increased, while the inflammatory cellular infiltrates of heart muscles diminished. Our results indicate that CD4+ T lymphocytes play a dual role in the immunopathology of acute experimental Chagas' disease.

Entities:  

Mesh:

Year:  1988        PMID: 2901844     DOI: 10.1016/0769-2625(88)90136-5

Source DB:  PubMed          Journal:  Ann Inst Pasteur Immunol        ISSN: 0769-2625


  19 in total

1.  Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection.

Authors:  M Saeftel; B Fleischer; A Hoerauf
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection.

Authors:  Andrea Henriques-Pons; Gabriel M Oliveira; Mauricio M Paiva; Alexandre F S Correa; Marcos M Batista; Rodrigo C Bisaggio; Chau-Ching Liu; Vinicius Cotta-De-Almeida; Claudia M L M Coutinho; Pedro M Persechini; Tania C Araujo-Jorge
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

3.  Modulation of thymocyte subsets during acute and chronic phases of experimental Trypanosoma cruzi infection.

Authors:  M C Leite-de-Moraes; M Hontebeyrie-Joskowicz; M Dardenne; W Savino
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

4.  Chronic experimental Chagas' disease: functional syngeneic T-B-cell cooperation in vitro in the absence of an exogenous stimulus.

Authors:  C Freire-de-Lima; L M Peçanha; G A Dos Reis
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Experimental infection with Trypanosoma cruzi increases the population of CD8(+), but not CD4(+), immunoglobulin G Fc receptor-positive T lymphocytes.

Authors:  Andrea Henriques-Pons; Bianca P Olivieri; Gabriel M Oliveira; Marc Daëron; Tania C de Araújo-Jorge
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.

Authors:  C R Marinho; M R D'Império Lima; M G Grisotto; J M Alvarez
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity.

Authors:  S Frosch; D Küntzlin; B Fleischer
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

8.  Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.

Authors:  C Hölscher; G Köhler; U Müller; H Mossmann; G A Schaub; F Brombacher
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

9.  Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.

Authors:  J S Silva; G N Vespa; M A Cardoso; J C Aliberti; F Q Cunha
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.

Authors:  R A Wrightsman; M J Miller; J L Saborio; J E Manning
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.